Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$AGN, $AGR, $BP,  $EPZM

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:

Allergan PLC (NYSE:AGN) was started with a Buy rating and assigned a 220 price target at Citigroup.

Avangrid Inc. (NYSE:AGR) was maintained as Buy with a 55 fair value at Janney. Merrill Lynch maintained it as Buy with a 54 price objective.

BP PLC (NYSE:BP) was raised to Buy from Neutral with a 54 price target at Goldman Sachs. BP’s American depository shares finished at 44.24 Tuesday. The consensus price target is 45.20, the 52-wk trading range is 33.90 – 44.62.

Epizyme Inc. (NASDAQ:EPZM) was maintained as Outperform but the price target was cut to 20 from 24 at Wedbush. The firm believes that the secondary malignancy causing a partial hold looks to be a 1-off event and the long-term thesis remains intact. Shares finish at 13.oo Tuesday.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH